GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents61,64545,51840,40432,533
Short Term Investments148,14984,05756,58562,410
Net Receivables51,53131,16135,17937,164
Inventory----
Other Current Assets----
Total Current Assets274,836174,260145,964142,950
Long Term Investments4,066-5,800-
Property, plant and equipment39,53246,44045,68839,746
Goodwill----
Intangible Assets----
Accumulated Amortization----
Other Assets15,93810,9173,6621,921
Deferred Long Term Asset Charges----
Total Assets334,372231,617201,114184,617
Current Liabilities
Accounts Payable8,8491562,8648,585
Short/Current Long Term Debt----
Other Current Liabilities2,5301,1571,5191,862
Total Current Liabilities59,77639,51641,17542,672
Long Term Debt----
Other Liabilities4,4363,8103,8342,410
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities64,21243,32645,00945,082
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock3333
Retained Earnings-206,325-245,945-242,088-228,169
Treasury Stock-30,197-30,404-28,912-27,358
Capital Surplus506,679464,637427,102395,059
Other Stockholder Equity-87-2941,1982,752
Total stockholders' equity270,160188,291156,105139,535
Net Tangible Assets270,160188,291156,105139,535